DrugPatentWatch Database Preview
Alpharma Us Pharms Company Profile
What is the competitive landscape for ALPHARMA US PHARMS, and what generic and branded alternatives to ALPHARMA US PHARMS drugs are available?
ALPHARMA US PHARMS has sixty-one approved drugs.
Summary for Alpharma Us Pharms
| US Patents: | 0 |
| Tradenames: | 43 |
| Ingredients: | 40 |
| NDAs: | 61 |
Drugs and US Patents for Alpharma Us Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpharma Us Pharms | FLUOCINOLONE ACETONIDE | fluocinolone acetonide | CREAM;TOPICAL | 088361-001 | Jan 16, 1984 | DISCN | No | No | Start Trial | Start Trial | |||||
| Alpharma Us Pharms | ERYTHROMYCIN ETHYLSUCCINATE | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062200-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Alpharma Us Pharms | ERYTHROMYCIN ETHYLSUCCINATE | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062200-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Alpharma Us Pharms | DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride | SYRUP;ORAL | 070497-001 | Apr 25, 1989 | DISCN | No | No | Start Trial | Start Trial | |||||
| Alpharma Us Pharms | FLUOCET | fluocinolone acetonide | CREAM;TOPICAL | 088360-001 | Jan 16, 1984 | DISCN | No | No | Start Trial | Start Trial | |||||
| Alpharma Us Pharms | TRIPLE SULFA | trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) | SUSPENSION;ORAL | 080280-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Alpharma Us Pharms | NYSTATIN | nystatin | SUSPENSION;ORAL | 062571-001 | Oct 29, 1985 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alpharma Us Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alpharma Us Pharms | SERAX | oxazepam | CAPSULE;ORAL | 015539-002 | Approved Prior to Jan 1, 1982 | 4,620,974 | Start Trial |
| Alpharma Us Pharms | SERAX | oxazepam | CAPSULE;ORAL | 015539-006 | Approved Prior to Jan 1, 1982 | 4,620,974 | Start Trial |
| Alpharma Us Pharms | SERAX | oxazepam | CAPSULE;ORAL | 015539-004 | Approved Prior to Jan 1, 1982 | 4,620,974 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
